In recent years, MDMA therapy has emerged as a potential psychiatric treatment in a ketamine clinic setting. Many patients have questions about whether it is appropriate for them as part of a structured mental health care plan by a psychiatrist. The following blog answers some of the most the common questions about MDMA therapy and what you can expect from the treatment process.
MDMA therapy, or MDMA-assisted therapy (MDMA-AT), refers to the clinically supervised use of 3,4-methylenedioxymethamphetamine, colloquially known as "ecstasy" or "molly," as part of a comprehensive treatment plan in psychotherapy. Unlike the recreational use of MDMA, this approach follows strict medical and ethical guidelines as laid out by the Food and Drug Administration (FDA). In research settings, the treatment is conducted under the care of a licensed psychiatrist and integrated into a broader psychotherapy treatment plan.
On a federal level, MDMA therapy is not legal for general medical use in the United States. Its use in psychotherapy is still being researched in clinical trials. In 2017, the FDA granted it "breakthrough therapy" designation for post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), suggesting it may be approved for broader medical use in the future.
As of August 2024, the FDA advisory panel voted against approving MDMA-AT for PTSD and requested additional Phase 3 trials to understand its long-term effects and safety. This means that it is not yet approved for clinical usage and requires further research to address potential for misuse, standardized treatment protocols, and the psychological impacts of MDMA outside of controlled medical environments. At the end of the day, MDMA remains a Schedule I controlled substance.
Researchers have primarily researched MDMA therapy in the treatment of PTSD and MDD as part of a comprehensive treatment plan. However, they have also considered using MDMA therapy for those with complex trauma, treatment-resistant depression (TRD), and certain anxiety disorders. Before the clinical trial begins, the research team has each patient undergo a comprehensive assessment, including their mental health history, physical health, and current medications.
As explored in clinical trials, MDMA therapy consists of three distinct types of sessions: preparatory, MDMA, and integration sessions. Before the patient undergoes MDMA treatment, they undergo three 90-minute preparatory sessions to educate them about the treatment and build trust in the psychiatric team. They will also work with the psychiatrist to establish clear therapeutic goals.
Then, the patient will move into the active treatment phase. A course of treatment involves two to three MDMA sessions. Most of these treatments last 6-8 hours and are scheduled once a week for 1 month. MDMA sessions typically involve two doses. The first dose is a full dose of 75–125 mg (80–120 mg in the most recent Phase 3 clinical trials). A supplemental dose, half of the initial amount, is offered 90–120 minutes later based on the patient's tolerance and the psychiatrist's professional judgment.
After each MDMA session, the patient will participate in three 90-minute integration sessions for a total of six to nine integration sessions per course of treatment. The first integration session happens the morning after the MDMA session. Meanwhile, the second and third sessions followed at about one-week intervals before the next MDMA session.
In controlled research studies, patients undergoing MDMA therapy have mild to moderate side effects that do not last long after treatment. The most common side effects include:
It is important to note that MDMA therapy supervised by a licensed psychiatrist is different from taking MDMA recreationally. The potential benefits of MDMA for PTSD and MDD have been demonstrated when taken as directed during a course of psychotherapy.
Although both treatments are psychedelic medicines, MDMA therapy and ketamine treatment operate through different neurobiological mechanisms in the human brain. MDMA is a non-traditional psychedelic that primarily stimulates serotonin production. Meanwhile, ketamine targets the glutamate system, leading to rapid symptom relief.
Additionally, MDMA-AT emphasizes that patients engage more during the treatment session, as the open state produced by the medicine encourages them to challenge harmful memories. In contrast, ketamine therapy is quieter and more internal, offering more of a mental reset that allows patients to see and feel things that may have been inaccessible before. Another important distinction is that ketamine therapy is already FDA-approved for limited clinical usage, while MDMA therapy is still restricted to clinical research trials.
Do you have further questions about the future of MDMA therapy? The Future Psych Ketamine Clinics team is here to answer them. Call our Myrtle Beach office to learn more or to schedule a consultation.
Request an appointment here: https://mb.futurepsychsolutions.com or call Future Psych Ketamine Clinics at (843) 788-9718 for an appointment in our Myrtle Beach office.
Check out what others are saying about our services on Yelp: Mdma Therapy in Myrtle Beach, SC.
Almost everyone experiences a certain degree of anxiety at some point. However, an anxiety disorder is a serious mental health condition where anxiety gets out of control and interferes with one's ability to function daily and enjoy life. Perhaps you worry that you or a loved one struggles with an anxiety disorder and are unsure…
Anxiety disorders are becoming more and more common among children and teenagers. These disorders affect their emotional well-being and daily functioning. As a parent, guardian, or caregiver, it is important to provide young people with the necessary support and understanding to help them effectively navigate their anxiety. Establishing an effective support network can be instrumental…
Anxiety is a fact of life for almost everyone at some point, but when anxiety gets out of control, you could be suffering from an anxiety disorder. Psychiatrists are often among the first professionals people turn to when anxiety gets too much. These professionals can diagnose anxiety disorders and prescribe medication to help alleviate symptoms.Anxiety…
Fibromyalgia treatment involves multiple stages of evaluation, planning, and ongoing support. In the early stages, fibromyalgia treatment focuses on identifying symptom patterns and determining whether ketamine-assisted care is appropriate. Throughout the full process, these treatment sessions aim to improve comfort, function, and long-term management.The process begins with a detailed clinical assessment. A psychiatrist conducts an…